Facet Joint Injections, Medial Branch Blocks, and RFA in Personal Injury: The Pharmacy Lien Connection

James Wong — Founder & Pharmacist, LienScripts | February 19, 2026 | 8 min read

Facet joint pain is one of the most common and most litigated sources of post-traumatic spine pain. Learn how facet anatomy, diagnostic blocks, therapeutic injections, and radiofrequency ablation connect to oral medication needs — and how a pharmacy lien covers the medication component throughout the pathway.

Facet Joints: The Anatomy Behind Post-Traumatic Spine Pain

The spine's range of motion — bending, twisting, extending — is governed not just by the discs but by small paired joints on the posterior aspect of each vertebral level. These are the facet joints, formally called zygapophyseal joints or Z-joints. Each vertebra has two superior and two inferior articular processes; the meeting of a superior process from the lower vertebra and the inferior process of the vertebra above forms one facet joint. There are two facet joints at every spinal level, one on each side.

Facet joints are true synovial joints: they have cartilage, a joint capsule, and synovial fluid. Like any synovial joint in the body, they are vulnerable to traumatic injury, capsular tearing, cartilage damage, and post-traumatic arthritis. Unlike disc pathology, facet joint injury does not typically appear on standard MRI sequences — making it a frequently underdiagnosed pain generator that is overlooked by insurers and misunderstood by juries.

[!KEY] Because facet joint pain does not show on most standard imaging, it is a contested injury in personal injury litigation. A properly documented diagnostic block series — combined with oral medication records — creates the objective evidence trail that supports causation and damages.

How MVAs Injure Facet Joints

Motor vehicle accidents produce two primary mechanisms of facet joint injury:

Compression/impaction — During a rear-end collision, the cervical spine undergoes rapid hyperextension before the head restraint limits the motion. This hyperextension phase compresses the posterior elements, including the facet joints, causing cartilage impaction, subchondral fracture of the articular processes, and capsular tear. In higher-energy impacts, small intra-articular fractures may occur.

Distraction/tearing — The subsequent forward flexion phase (whiplash rebound) stretches the posterior ligamentous complex and the facet joint capsule. The capsule has a rich nociceptive innervation — tearing the capsule creates immediate and persistent pain signaling.

Lumbar facet joints are similarly vulnerable in rear-end collisions (the lumbar spine also extends during the impact) and in any event that causes sudden axial loading, such as a fall from height or a severe frontal collision.

Cervical facet joints at C2–3, C5–6, and C6–7 are the most frequently injured levels in MVA. Lumbar facet joints at L4–5 and L5–S1 are the most commonly symptomatic levels in lumbar post-traumatic pain.

Types of Facet Joint Procedures: Diagnostic vs. Therapeutic

Facet joint corticosteroid injection (intra-articular injection) — A needle is advanced under fluoroscopic guidance into the facet joint space itself, and a small volume of corticosteroid (methylprednisolone or triamcinolone) combined with local anesthetic (lidocaine or bupivacaine) is deposited directly into the joint. This can be both diagnostic (confirming the joint as a pain source) and therapeutic (reducing intra-articular inflammation).

Medial branch block (MBB) — The facet joint is innervated by the medial branches of the dorsal rami of the spinal nerves. Blocking the medial branch nerve with local anesthetic confirms that a given facet joint is generating the patient's pain. MBBs are primarily diagnostic; the anesthetic is short-acting, and pain relief is expected to last only hours to days. Two separate MBBs producing consistent relief are typically required before proceeding to radiofrequency ablation.

Radiofrequency ablation (RFA) — Also called radiofrequency neurotomy or denervation, RFA applies thermal energy through a specialized electrode to coagulate the medial branch nerve that innervates the facet joint. When successful, RFA can produce pain relief lasting 6–24 months, until the nerve regenerates. RFA represents the most durable intervention in the facet joint treatment pathway.

[!SOURCE] Cohen SP, et al. "Randomized Placebo-Controlled Study Evaluating Lateral Branch Radiofrequency Denervation for Sacroiliac Joint Pain." Anesthesiology. 2008;109(2):279–288. PMID: 18648237. Demonstrates the value of diagnostic block confirmation prior to proceeding with radiofrequency ablation — the same principle applies in cervical and lumbar facet pathology.

Medications Used in Facet Joint Procedures

Corticosteroids are the primary therapeutic agents for intra-articular facet joint injections. The most commonly used agents include:

• Methylprednisolone acetate — particulate steroid; effective in intra-articular use
• Triamcinolone acetonide — particulate steroid; long-standing clinical use in facet injections
• Betamethasone — non-particulate; used when the physician prefers a non-particulate agent

Local anesthetics are co-injected for both intra-articular and medial branch block procedures:

• Lidocaine (1–2%) — short-acting; used in diagnostic blocks where duration of relief is being measured
• Bupivacaine (0.25–0.5%) — longer-acting; used in therapeutic intra-articular injections to extend immediate relief

These injectables are administered at the procedure facility and are not dispensed through a pharmacy lien program. The pharmacy lien focuses on the oral and topical medications the patient uses throughout the diagnostic and therapeutic pathway.

How Facet Pathology Drives Oral Medication Need

Patients with significant facet joint pathology require oral pharmacotherapy not just while waiting for injections, but throughout the entire multi-month treatment course. The diagnostic pathway — two separate MBB series, followed by RFA if positive — can span 4–8 months or more. During this time, oral medications are the primary tool for maintaining function and managing daily pain.

NSAIDs are first-line for facet-mediated pain. Meloxicam (7.5–15 mg daily), naproxen sodium (500 mg twice daily), and celecoxib (200 mg daily for GI-sensitive patients) reduce synovial inflammation and joint capsule irritation. These are often prescribed on a scheduled basis rather than as-needed to maintain consistent anti-inflammatory coverage.

Gastroprotective agents — Any patient on scheduled NSAID therapy should receive concurrent gastric protection. Omeprazole (20–40 mg daily) or pantoprazole (40 mg daily) reduces NSAID-related gastric injury risk. The pharmacy lien covers both the NSAID and the gastroprotective agent.

Gabapentinoids — Facet joint capsule tears and chronic facet-mediated pain frequently involve a central sensitization component, especially in patients with cervical levels. Gabapentin (300–900 mg three times daily) or pregabalin (75–150 mg twice daily) addresses this neuropathic pain dimension.

Muscle relaxants — Protective muscle spasm around injured facet joints is nearly universal. Tizanidine, cyclobenzaprine, or methocarbamol are commonly prescribed alongside NSAIDs to address the muscular component that overlays the joint pain.

Topical analgesics — Diclofenac 1% gel and lidocaine patches applied over the painful spinal region provide local analgesia with minimal systemic absorption — useful between injection appointments and throughout the pre-RFA diagnostic period.

[!KEY] The pharmacy lien record for a patient undergoing a full facet joint treatment pathway — intra-articular injections, medial branch block series, and RFA — can span 6–12 months of continuous oral medication fills. This duration itself is a damages element, demonstrating the persistence and severity of the injury.

What a Positive Medial Branch Block Means for RFA Candidacy

A positive diagnostic MBB — typically defined as 80% or greater pain relief for the expected duration of the local anesthetic used — confirms that the medial branch nerve (and therefore the facet joint it innervates) is a significant pain generator. Most interventional pain protocols require two confirmatory MBBs with consistent positive responses before proceeding to RFA.

From a litigation standpoint, the positive MBB is important documentation. It establishes:

1. The pain was arising from a specific anatomical structure (the facet joint at a confirmed level).
2. The injury was sufficient to require a multi-step interventional treatment course.
3. RFA — a more durable and more expensive procedure — was medically necessary and preceded by proper diagnostic confirmation.

A negative MBB (inadequate pain relief) redirects the diagnostic workup — suggesting disc pathology, nerve root irritation, or a different pain generator requires evaluation.

Documenting the Injection-to-RFA Pathway in the Demand Package

The facet joint treatment pathway, when fully documented, creates one of the most compelling special damages narratives in a spine injury PI case:

1. Initial clinical assessment — pain physician note documenting posterior spine tenderness, pain with extension and rotation, and clinical suspicion of facet-mediated pain.
2. Intra-articular injection records (if performed) — fluoroscopy report, medication administered, and response documented.
3. First MBB series records — levels blocked, local anesthetic used, response percentage documented at defined time intervals.
4. Second confirmatory MBB records — confirming positive response, establishing RFA candidacy.
5. RFA procedure records — levels ablated, electrode placement under fluoroscopy, post-procedure care instructions.
6. Post-RFA follow-up notes — documenting duration of relief, percentage improvement, and any need for repeat RFA as nerve regenerates.
7. Pharmacy lien medication summary — all oral medications filled across the entire pathway duration.

This record, presented chronologically in the demand package, shows an insurer or defense counsel a patient who required 6–12+ months of continuous interventional care, multiple procedure sessions, and sustained oral pharmacotherapy — all causally linked to the accident.

Coordinating the Pharmacy Lien Across the Facet Pathway

LienScripts works with personal injury attorneys and pain management physicians to ensure the oral medication component is covered from the first prescription. For patients undergoing the facet joint treatment pathway, the lien program can:

• Fill NSAIDs, muscle relaxants, gabapentinoids, and gastroprotective agents beginning at the first pain management visit — before the first injection appointment.
• Continue filling oral medications throughout the multi-month diagnostic block series.
• Maintain medication coverage post-RFA during the recovery period and any subsequent treatment.
• Provide the attorney with a complete, chronologically organized medication summary at demand package assembly.

This coordination ensures patients maintain their oral medication regimen throughout the entire treatment pathway — which is essential both for clinical outcomes and for building the continuous treatment record that supports the damages claim.

Related Resources

• Epidural Steroid Injections in Personal Injury: Medications and the Pharmacy Lien
• Gabapentin vs. Pregabalin for Nerve Pain After a Personal Injury
• Herniated Disc Medications and the Pharmacy Lien
• What Is a Pharmacy Lien? A Plain-Language Guide